MedPath

Psychoeducational Videos and Digital Assessments for BPD

Not Applicable
Active, not recruiting
Conditions
Borderline Personality Disorder
Interventions
Other: Non-BPD-related Educational Videos
Other: Psychoeducational Videos
Other: Neuropsychological Feedback
Registration Number
NCT05358925
Lead Sponsor
Mclean Hospital
Brief Summary

In this study, 100 adults who were recently diagnosed with borderline personality disorder (BPD) will be randomized to either receive educational videos about BPD or educational videos about other topics. All participants in both conditions will complete daily surveys about their emotions and social interactions, and they will respond to surveys and complete cognitive tests at 4 different time points. Some participants will receive feedback about their cognitive test performance, and others will not. The investigators are interested in learning about how accurate education about BPD and enhanced knowledge about cognitive abilities might help people manage their BPD symptoms. The investigators expect that participants who received psychoeducation about BPD will have lower levels of BPD and depressive symptoms than other participants, and that participants who received feedback on their cognitive tests will also have lower symptoms.

Detailed Description

In this study, 100 adults who were diagnosed with BPD within the past three months will be randomly assigned to receive psychoeducational videos (4-10 minutes each) about the development, symptoms, naturalistic trajectory, and treatment of BPD (2/3 of participants) or matched-length videos about non-BPD, health-related topics (1/3 of participants). One video will be delivered every business day for two weeks. Participants will respond to 5-minute surveys on their recent social interactions, their feelings of threat, connectedness, and aloneness, and will complete a 1-minute version of the Continuous Performance Test (CPT) and Digit Symbol Matching Test, every day for 30 days. Participants will complete additional full-length surveys and cognitive tests at 4 time points: baseline (Day 1), Time 2 (day 15), Time 3 (Day 30), and Follow-up (day 60). The primary outcome is BPD symptom severity, and the secondary outcome is depressive symptom severity. The investigators expect that BPD-focused psychoeducation and personalized neuropsychological feedback will each lead to separate, measurable reductions in BPD and depressive symptom severity. The investigators also expect that the relationship between psychoeducation and symptom reduction will be mediated by increased knowledge about BPD, and that the relationship between neuropsychological feedback and symptom reduction will be mediated by increased cognitive control.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • reliable access to a smartphone with a data plan for the duration of the study
  • ability to speak and understand English
  • age 18 years or older
  • diagnosis of BPD within the past 6 months
  • awake and able to complete EMA surveys between 9:00am and 9:00pm on most days
  • located within the United States
Exclusion Criteria
  • cognitive disability that impedes ability to participate in the study
  • current psychiatric symptoms that interfere with the individual's ability to provide consent or complete the research procedures (e.g., acute mania, acute psychosis, eating disorder threatening medical stability).

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Non-BPD Videos and No FeedbackNon-BPD-related Educational VideosTen daily 4-10 minute educational videos about health-related topics other than BPD.
BPD Videos and No FeedbackPsychoeducational VideosTen daily 4-10 minute psychoeducational videos about BPD.
BPD Videos and FeedbackPsychoeducational VideosTen daily 4-10 minute psychoeducational videos about BPD and personalized feedback about performance on neuropsychological tasks.
BPD Videos and FeedbackNeuropsychological FeedbackTen daily 4-10 minute psychoeducational videos about BPD and personalized feedback about performance on neuropsychological tasks.
Primary Outcome Measures
NameTimeMethod
Borderline Symptom List 23 (BSL-23)Baseline (day 1), Time 2 (day 15), Time 3 (day 30), Follow-Up (day 60)

Change (increase or decrease) in BSL-23 mean score (average score across all 23 items) at time 2, time 3, and follow-up, as compared to baseline. Minimum score = 0, maximum score = 4. A higher score indicates more severe BPD symptoms.

Secondary Outcome Measures
NameTimeMethod
Patient Health Questionnaire (PHQ-9)Baseline (day 1), Time 2 (day 15), Time 3 (day 30), Follow-Up (day 60)

Change (increase or decrease) in PHQ-9 total score at time 2, time 3, and follow-up, as compared to baseline. Minimum score = 0, maximum score = 27. A higher score indicates more severe depressive symptoms.

Trial Locations

Locations (1)

McLean Hospital

🇺🇸

Belmont, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath